scispace - formally typeset
Journal ArticleDOI

Effects of Acetylsalicylic Acid Ingestion on Maternal and Neonatal Hemostasis

TLDR
It is concluded that aspirin should be avoided during pregnancy because of the effects of maternal ingestion of acetylsalicylic acid (aspirin) within 10 days of delivery on maternal and neonatal hemostasis.
Abstract
In a case-control study, we evaluated the effects of maternal ingestion of acetylsalicylic acid (aspirin) within 10 days of delivery on maternal and neonatal hemostasis. Only one of 34 control maternal-neonatal pairs (3 per cent) had hemostatic abnormalities. In 10 pairs, when maternal aspirin ingestion occurred within five days of delivery, 6 of 10 mothers and 9 of the 10 infants had bleeding tendencies. Seven maternal-neonatal pairs in which aspirin was ingested 6 to 10 days before delivery were free of clinical bleeding. Among seven other mothers who ingested aspirin in the immediate post-partum period four of the seven (57 per cent) also had impaired hemostasis. Neonatal hemostatic abnormalities included numerous petechiae over the presenting part, hematuria, a cephalhematoma, subconjunctival hemorrhage, and bleeding from a circumcision. Maternal bleeding was confined to excessive intrapartum or post-partum blood loss. We conclude that aspirin should be avoided during pregnancy. If ingestion has occurred within five days of delivery, the neonate should be evaluated for the presence of bleeding.

read more

Citations
More filters
Journal ArticleDOI

Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae.

TL;DR: Low-dose aspirin may restore prostacyclin/thromboxane imbalance, previously suggested as an important aetiological factor in PIH and pre-eclampsia, and be reinstated in mothers or infants.
Journal ArticleDOI

VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

TL;DR: In this article, the authors focused on the management of VTE and thrombophilia as well as the use of antithrombotic agents during pregnancy. But they did not consider the risk of pregnancy complications.
Journal ArticleDOI

Prevention of pre-eclampsia by early antiplatelet therapy

TL;DR: Antiplatelet therapy given early in pregnancy to high-risk patients may protect against pre-eclampsia and fetal growth retardation.
References
More filters
Journal ArticleDOI

Inhibition of platelet prostaglandin synthetase by oral aspirin.

TL;DR: Platelet cyclooxygenase is more sensitive to inactivation by aspirin than enzyme in sheep seminal vesicles, which suggests that oral aspirin also inactivated megakaryocyte cyclo oxygengenase.
Journal ArticleDOI

A simple nonradioisotope technic for the determination of platelet life-span.

TL;DR: A normal platelet survival curve was constructed with a mean half-life of 4.4 days (range of 2.9 to 5.9 days) and values agree with the standard 51-Cr survivals in three patients with chronic idiopathic thrombocytopenic purpura.
Journal ArticleDOI

Altered Platelet Function in Newborns

TL;DR: In vitro mixing experiments suggested that the impaired ADP platelet aggregation was due neither to the presence of plasma ADP inhibitors, a refractory state due to increased circulating levels of ADP, anticoagulants, nor to a selected population of platelets.
Journal ArticleDOI

The effects of antenatal drug administration on aggregation of platelets of newborn infants.

TL;DR: In vitro testing demonstrated that platelets of newborn infants are much more susceptible to the effects of membrane-active drugs than are those of adults.
Related Papers (5)